Top Chemed Insider Cashes In on a Major Stock Move
TipRanks (Mon, 21-Sep 10:00 PM ET)
Healthcare stocks with the strongest dividend growth grades
Seeking Alpha News (Mon, 21-Sep 6:33 AM ET)
Roto-Rooter Buys Largest Franchisee Territory
Globe Newswire (Wed, 16-Sep 4:30 PM ET)
Chemed Corporation to Present at the Jefferies 2026 Healthcare Services Conference
Globe Newswire (Tue, 8-Sep 9:00 AM ET)
Business Wire (Thu, 3-Sep 4:06 PM ET)
Chemed Corporation Declares Quarterly Dividend of 70 Cents
Globe Newswire (Thu, 6-Aug 11:57 AM ET)
Chemed Reports Second-Quarter 2026 Results
Globe Newswire (Tue, 28-Jul 4:15 PM ET)
Chemed To Report Second Quarter 2026 Earnings July 28, Related Conference Call To Be Held On July 29
Globe Newswire (Wed, 1-Jul 9:00 AM ET)
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
Chemed trades on the NYSE stock market under the symbol CHE.
As of September 24, 2026, CHE stock price declined to $496.67 with 50,837 million shares trading.
CHE has a beta of 0.22, meaning it tends to be less sensitive to market movements. CHE has a correlation of 0.01 to the broad based SPY ETF.
CHE has a market cap of $6.59 billion. This is considered a Mid Cap stock.
Last quarter Chemed reported $673 million in Revenue and $6.06 earnings per share. This beat revenue expectation by $9 million and exceeded earnings estimates by $.56.
In the last 3 years, CHE traded as high as $654.62 and as low as $365.21.
The top ETF exchange traded funds that CHE belongs to (by Net Assets): VTI, VB, VBK, VXF, XMHQ.
CHE has underperformed the market in the last year with a price return of +10.0% while the SPY ETF gained +16.7%. However, in the short term, CHE had mixed performance relative to the market. It has outperformed in the last 3 months, returning +12.0% vs +4.7% return in SPY. But in the last 2 weeks, CHE shares have been beat by the market, returning -4.2% compared to an SPY return of +0.8%.
CHE support price is $489.02 and resistance is $507.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CHE shares will trade within this expected range on the day.